Related references
Note: Only part of the references are listed.Treatment of Tobacco Smoking A Review
Nancy A. Rigotti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial
Paul M. Cinciripini et al.
DEPRESSION AND ANXIETY (2022)
Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia
Samantha Johnstone et al.
DRUG AND ALCOHOL DEPENDENCE (2022)
The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials
Kangle Guo et al.
ADDICTIVE BEHAVIORS (2022)
Person-years of life lost and lost earnings from cigarette smoking-attributable cancer deaths, United States, 2019
Farhad Islami et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink
Neil M. Davies et al.
HEALTH TECHNOLOGY ASSESSMENT (2020)
Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis
Timothy Tanzer et al.
PSYCHOPHARMACOLOGY (2020)
Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan
Yuji Higuchi et al.
BMC PSYCHIATRY (2019)
Nicotine dependence in Croatian male inpatients with schizophrenia
Marina Sagud et al.
BMC PSYCHIATRY (2018)
Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports
Allan Hackshaw et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports
Allan Hackshaw et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial
Omara Dogar et al.
ADDICTION (2018)
Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
Saeed Ahmed et al.
FRONTIERS IN PSYCHIATRY (2018)
The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials
Taoyi Yang et al.
ACTA PHARMACEUTICA SINICA B (2017)
Nicotine receptor partial agonists for smoking cessation
Kate Cahill et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Premature Mortality Among Adults With Schizophrenia in the United States
Mark Olfson et al.
JAMA PSYCHIATRY (2015)
Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis
Taro Kishi et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
Pharmacological Treatments for Smoking Cessation
Kate Cahill et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain
S. S. Kaalund et al.
MOLECULAR PSYCHIATRY (2014)
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Walter N. Kernan et al.
STROKE (2014)
Comorbidity of Severe Psychotic Disorders With Measures of Substance Use
Sarah M. Hartz et al.
JAMA PSYCHIATRY (2014)
Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
Jared W. Young et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Elevated cord serum manganese level is associated with a neonatal high ponderal index
XiaoDan Yu et al.
ENVIRONMENTAL RESEARCH (2013)
Cigarette Smoking Among Persons With Schizophrenia or Bipolar Disorder in Routine Clinical Settings, 1999–2011
Faith Dickerson et al.
PSYCHIATRIC SERVICES (2013)
A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation
Helene M. Faessel et al.
CLINICAL PHARMACOKINETICS (2010)
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
Julio Bobes et al.
SCHIZOPHRENIA RESEARCH (2010)
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
Arzu Gunes et al.
PHARMACOGENOMICS (2008)
Exacerbation of schizophrenia by varenicline
Robert Freedman
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder
M. Berk et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Share Paper
